QuidelOrtho Corporation

NASDAQ:QDEL

Medical - Instruments & Supplies

Healthcare
$9.57 +0.72%

+$0.09 today

Market cap
$656.62M
Beta
0.76
P/E (TTM)
-0.7
EPS (TTM)
-$17.76
52W Low $9.92High $35.58

Volume 2.13M

Average 2.35M

QDEL EBITDA Margin

EBITDA as a percentage of revenue.

QuidelOrtho CorporationNASDAQ: QDEL

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 13.1%

EBITDA Margin was 13.1% in Q1 FY2026, down 7.2 pp from a year earlier. On a trailing-twelve-month basis it was -20.7%, down 31.1 pp year over year. Over 3 fiscal years it narrowed by 51.4 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 25.3% for the fiscal year ending Dec 2026, up from -17.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
13.1%+7.2 pp QoQ
Last fiscal yearDec 2025
-17.9%+35.7 pp YoY
LTMMar 2026
-20.7%-31.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-7.2 pp+20.1 pp+27.3 pp
1 year+35.7 pp+43.1 pp+7.5 pp
3 years-51.4 pp+43.6 pp+95.0 pp
5 years+37.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-17.9%
Year-over-year change
+35.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How QDEL compares with its peers on the latest reported figures

  • QDEL's LTM Mar 2026 EBITDA Margin of -20.7% is the 8th highest of the 9 companies compared; the peer median is 19.7%.
  • Its year-over-year change of -31.1 pp is the 8th highest of 9, against a peer median of -2.6 pp.
  • Over three fiscal years its change of -51.4 pp compares with a peer median of +0.3 pp.
QDEL Competitors Peer median
EBITDA Margin for QDEL and competitors
Company Period LTM level YoY 3-year change
NNNNAnbio Biotechnology Class A Ordinary SharesFY202566.7% +35.3 pp+24.1 pp
RVTYRevvity, Inc.LTM Jul 202626.3% -3.0 pp-8.9 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202623.7% -2.2 pp-0.9 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202619.9% -6.2 pp+208.5 pp
DGXQuest Diagnostics IncorporatedLTM Sep 202619.4% -0.3 pp+1.5 pp
OPKOPKO Health, Inc.LTM Mar 2026-6.0% -27.8 pp+20.2 pp
TRIBTrinity Biotech plcLTM Dec 2025-19.5% +7.9 pp-22.1 pp
QDELQuidelOrtho CorporationLTM Mar 2026-20.7% -31.1 pp-51.4 pp
OSUROraSure Technologies, Inc.LTM Mar 2026-56.4% -42.7 pp-49.1 pp
Peer median (excluding QDEL) 19.7%-2.6 pp+0.3 pp

Competitors are the stored peer set for QDEL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Jan 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.7B3.27B3B2.78B2.73B
Cost of Revenue420.3M1.33B1.5B1.5B1.46B
Gross Profit1.28B1.94B1.5B1.29B1.27B
Gross Margin75.3%59.3%49.9%46.2%46.7%
Research & Development95.7M187.9M246.8M218.7M186.2M
Selling, General & Admin239.6M621M763.2M766.8M746.3M
Operating Expenses372.3M1.09B1.36B3.25B2.19B
Depreciation & Amortization52.7M283.6M457.2M453.4M442M
EBITDA953.3M1.09B607M(1.49B)(488.1M)
EBITDA Margin56.1%33.5%20.2%-53.5%-17.9%
Operating Income906M843.7M139.1M(1.96B)(919.2M)
Operating Margin53.3%25.8%4.6%-70.5%-33.7%
Interest Income300K1.3M2.2M00
Interest Expense700K74.5M178.9M188.3M177.6M
Other Income / Expenses(5.7M)(107.8M)(168.2M)(170.6M)(188.5M)
Income Before Tax900.3M735.9M(29.1M)(2.13B)(1.11B)
Pre-Tax Margin53.0%22.5%-1.0%-76.6%-40.6%
Income Tax Expense196.1M187.2M(19M)(79.5M)24.1M
Net Income704.2M548.7M(10.1M)(2.05B)(1.13B)
Net Margin41.5%16.8%-0.3%-73.7%-41.5%
EPS (Basic)16.749.66(0.15)(30.54)(16.69)
EPS (Diluted)16.439.56(0.15)(30.54)(16.69)
Weighted Avg Shares42.08M56.8M66.8M67.2M67.8M
Weighted Avg Shares (Diluted)42.87M57.4M66.8M67.2M67.8M

QuidelOrtho Corporation

NASDAQ:QDEL

Intrinsic Alpha fair value

Locked

Current Price

$9.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.